{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:26:57Z","timestamp":1787023617618,"version":"build-2736575974"},"reference-count":28,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,31]]},"DOI":"10.18632\/oncotarget.14448","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T07:40:46Z","timestamp":1483429246000},"page":"8765-8774","source":"Crossref","is-referenced-by-count":83,"title":["The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Cl\u00e9mentine","family":"Sarkozy","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d\u2019H\u00e9matologie, 69495 Pierre B\u00e9nite Cedex, France"},{"name":"NSERM1052, CNRS 5286, Universit\u00e9 Claude Bernard, Facult\u00e9 de M\u00e9decine Lyon-Sud Charles M\u00e9rieux Lyon-1, 69495 Pierre B\u00e9nite Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Huet","sequence":"additional","affiliation":[{"name":"NSERM1052, CNRS 5286, Universit\u00e9 Claude Bernard, Facult\u00e9 de M\u00e9decine Lyon-Sud Charles M\u00e9rieux Lyon-1, 69495 Pierre B\u00e9nite Cedex, France"},{"name":"Hospices Civils De Lyon, Laboratoire d\u2019H\u00e9matologie, Pierre B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E.H.","family":"Carlton","sequence":"additional","affiliation":[{"name":"Adaptive Biotechnologies Corp., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Assistance Publique - H\u00f4pitaux de Paris, H\u00f4pital Saint-Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Delmer","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, CHU de Reims, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Jardin","sequence":"additional","affiliation":[{"name":"Centre Henri Becquerel, Service d\u2019H\u00e9matologie, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Helene","family":"Delfau-Larue","sequence":"additional","affiliation":[{"name":"Department of Biological Hematology and Immunology, Assistance Publique - H\u00f4pitaux de Paris, Groupe Hospitalier Mondor, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Hacini","sequence":"additional","affiliation":[{"name":"Centre Hospitalier de Chambery, Service d\u2019H\u00e9matologie, Chambery, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ribrag","sequence":"additional","affiliation":[{"name":"Institut Gustave Roussy, Service d\u2019H\u00e9matologie, Universit\u00e9 Paris-Sacley, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Guidez","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie, CHU de Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Faham","sequence":"additional","affiliation":[{"name":"Adaptive Biotechnologies Corp., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d\u2019H\u00e9matologie, 69495 Pierre B\u00e9nite Cedex, France"},{"name":"NSERM1052, CNRS 5286, Universit\u00e9 Claude Bernard, Facult\u00e9 de M\u00e9decine Lyon-Sud Charles M\u00e9rieux Lyon-1, 69495 Pierre B\u00e9nite Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,1,2]]},"reference":[{"key":"1","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"Vardiman","year":"2008"},{"key":"2","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1084\/jem.164.5.1566","article-title":"Idiotype variant cell populations in patients with B cell lymphoma","volume":"164","author":"Levy","year":"1986","journal-title":"J Exp Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Alizadeh","year":"2013","journal-title":"Blood"},{"key":"4","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.4049\/jimmunol.1401699","article-title":"Intraclonal Diversity in Follicular Lymphoma Analyzed by Quantitative Ultradeep Sequencing of Noncoding Regions","volume":"193","author":"Burack","year":"2014","journal-title":"J Immunol"},{"key":"5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Inghirami","year":"2014","journal-title":"Cell Rep"},{"key":"6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Pantel","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2012-07-444042","article-title":"Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia","volume":"120","author":"Campana","year":"2012","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/leu.2013.52","article-title":"Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia","volume":"27","author":"Miklos","year":"2013","journal-title":"Leukemia"},{"key":"9","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1182\/blood-2014-01-550020","article-title":"Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma","volume":"123","author":"Mateos","year":"2014","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(15)70106-3","article-title":"Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study","volume":"16","author":"Wilson","year":"2015","journal-title":"Lancet Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaoncol.2015.2010","article-title":"Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma","volume":"1","author":"Zuchlinski","year":"2015","journal-title":"JAMA Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2015-03-635169","article-title":"Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing","volume":"125","author":"Miklos","year":"2015","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.bbmt.2014.04.018","article-title":"Immunoglobulin and T cell receptor gene high-throughput sequencing quantifies minimal residual disease in acute lymphoblastic leukemia and predicts post-transplantation relapse and survival","volume":"20","author":"Miklos","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/leu.2013.375","article-title":"Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders","volume":"28","author":"Faham","year":"2014","journal-title":"Leukemia"},{"key":"15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bjh.13349","article-title":"Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach","volume":"169","author":"Younes","year":"2015","journal-title":"Br J Haematol"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Klinger, Zheng, Elenitoba-Johnson, Perkins, Faham, Bahler. Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation. Leukemia. 2015.","DOI":"10.1038\/leu.2015.351"},{"key":"17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","article-title":"Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial","volume":"377","author":"Leppa","year":"2011","journal-title":"Lancet"},{"key":"18","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2015-04-640912","article-title":"DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Tarte","year":"2015","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ajh.22099","article-title":"Follicular lymphoma: 2011 update on diagnosis and management","volume":"86","author":"Freedman","year":"2011","journal-title":"Am J Hematol"},{"key":"20","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1200\/JCO.2005.03.1674","article-title":"New treatment options have changed the survival of patients with follicular lymphoma","volume":"23","author":"Miller","year":"2005","journal-title":"J Clin Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"Di Raimondo","year":"2009","journal-title":"J Clin Oncol"},{"key":"22","first-page":"783","article-title":"Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases","volume":"95","author":"Rigacci","year":"2000","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Garcia-Conde","year":"2004","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Ducar","year":"2015","journal-title":"Lancet Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.leu.2403323","article-title":"Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL","volume":"18","author":"Yasuda","year":"2004","journal-title":"Leukemia"},{"key":"26","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1182\/blood-2014-02-553693","article-title":"Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma","volume":"123","author":"Salles","year":"2014","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood-2015-03-630012","article-title":"Prognostic value of circulating Bcl-2\/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy","volume":"126","author":"Barth","year":"2015","journal-title":"Blood"},{"key":"28","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2003-10-3411","article-title":"Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule","volume":"103","author":"Lohri","year":"2004","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:48:15Z","timestamp":1594817295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,1,31]]}},"alternative-id":["14448","28060738"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14448","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]}}}